Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 50022920
Affinity DataIC50: 0.700nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 27nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 39nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 90nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 135nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 147nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 147nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 176nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 229nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 244nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 257nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 275nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 276nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 310nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 335nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 340nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 398nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 399nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 426nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 435nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 445nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 457nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 486nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 497nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 562nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 563nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 569nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 679nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 703nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 781nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.11E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.12E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.53E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.61E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.62E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.63E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.74E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 1.75E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 2.14E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
Affinity DataIC50: 3.26E+3nMAssay Description:Inhibition of human ATX using LPC16:0 as substrate preincubated with compound for 20 mins followed by substrate addition and measured after 1 hr by f...More data for this Ligand-Target Pair
